Long-term effectiveness and safety of vedolizumab in ulcerative colitis: a real-world retrospective cohort study over 2 years.

Although these differences did not reach statistical significance—likely due to the limited sample size—the consistent trend across multiple parameters supports the interpretation that concomitant medication use serves as a clinical proxy for greater disease burden rather than a direct pharmacological interaction affecting VDZ efficacy.

also in 111,027 other papers